Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pioglitazone Regress Left Ventricular Mass in Type 2 Diabetes With Ischeamia Heart Disease

NCT01947790 is registered in ClinicalTrials.gov with Xiang Guang-da as lead sponsor.

NCT NCT01947790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01947790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pioglitazone Regress Left Ventricular Mass in Type 2 Diabetes With Ischeamia Heart Disease
Lead sponsor
Xiang Guang-da
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2013
Completion date
July 31, 2015
Enrollment
120 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

endothelial function, lvm, type 2 diabetic patients with ihd